We demonstrated that ERG SUMOylation contributes to the progression of AML, whereas the SUMO mutant ERG exhibited reduced ability to facilitate the proliferation and differentiation of AML cells (Figure 6). This evidence concerns the gene ERG and acute myeloid leukemia.